Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01476891
Other study ID # eCALM
Secondary ID
Status Active, not recruiting
Phase N/A
First received November 16, 2011
Last updated January 17, 2013
Start date January 2011

Study information

Verified date January 2013
Source AHS Cancer Control Alberta
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

For people with cancer, in-person Mindfulness-Based Stress Reduction (MBSR) participation can decrease stress symptoms, mood disturbance, and fatigue, as well as enhance personal growth and spirituality, and improve quality of life and sleep. Online MBSR may improve the accessibility of MBSR programs to underserved cancer patients who are unable to attend available in-person groups. This study will examine whether patients are willing to participate and complete the program, and also whether the online program improves mood and stress.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 64
Est. completion date
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Speak and read English sufficiently to complete questionnaires

- Women and men who have been diagnosed with any type of cancer, at any time in the past with no restriction on tumor site

- Pre or post primary cancer treatment, up to having completed primary cancer treatment within the last 36 months

- Exhibiting moderate distress

- Willing to participate in the intervention requirements; able to participate in the intervention (2 hrs per week for 8 weeks and a full day online retreat)

- Internet access

- Resident of Alberta, who has limited access to in-person cancer-specific MBSR programs

Exclusion Criteria:

- Presence of major self-reported psychiatric disorder not in remission, current substance abuse/dependence, and psychotic symptoms

- Previous participation in a MBSR program

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Cancer
  • Mindfulness-Based Stress Reduction (MBSR)

Intervention

Other:
Immediate MBSR
Immediate Online MBSR Group. Participation in a standardized manual-based 8-week online MBSR program.
Wait-list Control Group.
Wait-list Control Group. The control group will receive the next available online MBSR program.

Locations

Country Name City State
Canada Tom Baker Cancer Centre Calgary Alberta

Sponsors (2)

Lead Sponsor Collaborator
Alberta Health Services Tom Baker Cancer Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility recruitment, retention, attendance, adherence, satisfaction 44 months No
Secondary Efficacy Profile of Mood States (POMS), Calgary Symptoms of Stress Inventory (C-SOSI) 44 months No
Secondary Post-Traumatic Growth Inventory (PTGI) 44 months No
Secondary Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-Sp) 44 months No
Secondary Five Facet Mindfulness Questionnaire (FFMQ) 44 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links